References
Akerfelt M,
Morimoto RI and
Sistonen L
(2010)
Heat shock factors: integrators of cell stress, development and lifespan.
Nature Reviews. Molecular Cell Biology
11(8):
545–555.
Anelli T and
Sitia R
(2008)
Protein quality control in the early secretory pathway.
EMBO Journal
27(2):
315–327.
Balch WE,
Morimoto RI,
Dillin A and
Kelly JW
(2008)
Adapting proteostasis for disease intervention.
Science
319(5865):
916–919.
Broadley SA and
Hartl FU
(2008)
Mitochondrial stress signaling: a pathway unfolds.
Trends in Cell Biology
18(1):
1–4.
Campioni S,
Mannini B,
Zampagni M et al.
(2010)
A causative link between the structure of aberrant protein oligomers and their toxicity.
Nature Chemical Biology
6(2):
140–147.
Carrell RW and
Lomas DA
(1997)
Conformational disease.
Lancet
350(9071):
134–138.
Chiti F and
Dobson CM
(2006)
Protein misfolding, functional amyloid, and human disease.
Annual Review of Biochemistry
75:
333–366.
Cohen E,
Paulsson JF,
Blinder P et al.
(2009)
Reduced IGF‐1 signaling delays age‐associated proteotoxicity in mice.
Cell
139(6):
1157–1169.
Cuervo AM
(2010)
Chaperone‐mediated autophagy: selectivity pays off.
Trends in Endocrinology and Metabolism
21(3):
142–150.
Dill KA,
Ozkan SB,
Shell MS and
Weikl TR
(2008)
The protein folding problem.
Annual Review of Biophysics
37:
289–316.
Ellis RJ
(2001)
Macromolecular crowding: an important but neglected aspect of the intracellular environment.
Current Opinion in Structural Biology
11(1):
114–119.
Fernandez‐Funez P,
Nino‐Rosales ML,
de Gouyon B et al.
(2000)
Identification of genes that modify ataxin‐1‐induced neurodegeneration.
Nature
408(6808):
101–106.
Gersting SW,
Lagler FB,
Eichinger A et al.
(2010)
Pahenu1 is a mouse model for tetrahydrobiopterin‐responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo.
Human Molecular Genetics
19(10):
2039–2049.
Gregersen N,
Andresen BS,
Pedersen CB et al.
(2008)
Mitochondrial fatty acid oxidation defects – remaining challenges.
Journal of Inherited Metabolic Disease
31(5):
643–657.
Gregersen N and
Bross P
(2010)
Protein misfolding and cellular stress: an overview.
In: Bross P and
Gregersen N (eds)
Protein Misfolding and Cellular Stress in Disease and Aging,
pp. 3–23.
New York: Humana Press.
Gregersen N,
Bross P,
Vang S and
Christensen JH
(2006)
Protein misfolding and human disease.
Annual Review of Genomics and Human Genetics
7(1):
103–124.
Hansen JJ,
Dürr A,
Cournu‐Rebeix I et al.
(2002)
Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60.
American Journal of Human Genetics
70(5):
1328–1332.
Henriques BJ,
Olsen RK,
Bross P and
Gomes CM
(2010)
Emerging roles for riboflavin in functional rescue of mitochondrial beta‐oxidation flavoenzymes.
Current Medicinal Chemistry
17(32):
3842–3854.
Hutt D and
Balch WE
(2010)
Cell biology. The proteome in balance.
Science
329(5993):
766–767.
Irobi J,
Almeida‐Souza L,
Asselbergh B et al.
(2010)
Mutant HSPB8 causes motor neuron‐specific neurite degeneration.
Human Molecular Genetics
19(16):
3254–3265.
Kirstein‐Miles J and
Morimoto RI
(2010)
Peptides signal mitochondrial stress.
Cell Metabolism
11(3):
177–178.
Leandro P and
Gomes CM
(2008)
Protein misfolding in conformational disorders: rescue of folding defects and chemical chaperoning.
Mini Reviews in Medicinal Chemistry
8(9):
901–911.
Li H,
Fukuda S,
Hasegawa Y et al.
(2010)
Heat stress deteriorates mitochondrial beta‐oxidation of long‐chain fatty acids in cultured fibroblasts with fatty acid beta‐oxidation disorders.
Journal of Chromatography B. Analytical Technologies in the Biomedical and Life Sciences
878(20):
1669–1672.
Magen D,
Georgopoulos C,
Bross P et al.
(2008)
Mitochondrial hsp60 chaperonopathy causes an autosomal‐recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy.
American Journal of Human Genetics
83(1):
30–42.
Merksamer PI and
Papa FR
(2010)
The UPR and cell fate at a glance.
Journal of Cell Science
123(part 7):
1003–1006.
Mijaljica D,
Prescott M and
Devenish RJ
(2010a)
Autophagy in disease.
Methods in Molecular Biology
648:
79–92.
Mijaljica D,
Prescott M and
Devenish RJ
(2010b)
Mitophagy and mitoptosis in disease processes.
Methods in Molecular Biology
648:
93–106.
Mu TW,
Ong DS,
Wang YJ et al.
(2008)
Chemical and biological approaches synergize to ameliorate protein‐folding diseases.
Cell
134(5):
769–781.
Muntau AC and
Gersting SW
(2010)
Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.
Journal of Inherited Metabolic Disease
33(6):
649–658.
Ng PC and
Henikoff S
(2005)
Predicting the effects of amino acid substitutions on protein function.
Annual Review of Genomics and Human Genetics
7:
61–80.
Olsen RK,
Olpin SE,
Andresen BS et al.
(2007)
ETFDH mutations as a major cause of riboflavin‐responsive multiple acyl‐CoA dehydrogenation deficiency.
Brain
130(part 8):
2045–2054.
Perlmutter D
(2010)
Alpha‐1 antitrypsin deficiency: importance of proteasomal and autophagic degradative pathways in disposal of liver disease‐associated protein aggregates.
Annual Review of Medicine [epub ahead of print].
Powers ET,
Morimoto RI,
Dillin A,
Kelly JW and
Balch WE
(2009)
Biological and chemical approaches to diseases of proteostasis deficiency.
Annual Review of Biochemistry
78:
959–991.
Qu BH and
Thomas PJ
(1996)
Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway – effects of the Delta F508 mutation on the thermodynamic stability and folding yield of NBD1.
The Journal of Biological Chemistry
271(13):
7261–7264.
Rajasekaran NS,
Connell P,
Christians ES et al.
(2007)
Human alphaB‐crystallin mutation causes oxido‐reductive stress and protein aggregation cardiomyopathy in mice.
Cell
130(3):
427–439.
Rutherford SL and
Lindquist S
(1998)
Hsp90 as a capacitor for morphological evolution.
Nature
396(6709):
336–342.
Schapira AH
(2008)
Mitochondria in the aetiology and pathogenesis of Parkinson's disease.
Lancet Neurology
7(1):
97–109.
Schmidt SP,
Corydon TJ,
Pedersen CB,
Bross P and
Gregersen N
(2010)
Misfolding of short‐chain acyl‐CoA dehydrogenase leads to mitochondrial fission and oxidative stress.
Molecular Genetics and Metabolism
100(2):
155–162.
Tatsuta T and
Langer T
(2009)
AAA proteases in mitochondria: diverse functions of membrane‐bound proteolytic machines.
Research in Microbiology
160(9):
711–717.
Thusberg J and
Vihinen M
(2009)
Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods.
Human Mutation
30(5):
703–714.
Turner GC and
Varshavsky A
(2000)
Detecting and measuring cotranslational protein degradation in vivo.
Science
289(5487):
2117–2120.
Voos W
(2009)
Mitochondrial protein homeostasis: the cooperative roles of chaperones and proteases.
Research in Microbiology
160(9):
718–725.
Wang Z and
Moult J
(2001)
SNPs, protein structure, and disease.
Human Mutation
17(4):
263–270.
Ward CL and
Kopito RR
(1994)
Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild‐type and mutant proteins.
The Journal of Biological Chemistry
269(41):
25710–25718.
Ward CL,
Omura S and
Kopito RR
(1995)
Degradation of CFTR by the ubiquitin‐proteasome pathway.
Cell
83(1):
121–127.
Westermark P,
Benson MD,
Buxbaum JN et al.
(2007)
A primer of amyloid nomenclature.
Amyloid
14(3):
179–183.
Further Reading
Brorsson AC,
Kumita JR,
MacLeod I et al.
(2010)
Methods and models in neurodegenerative and systemic protein aggregation diseases.
Frontiers in Bioscience
15:
373–396.
Hartl FU and
Hayer‐Hartl M
(2009)
Converging concepts of protein folding in vitro and in vivo.
Nature Structural & Molecular Biology
16(6):
574–581.
Luheshi LM and
Dobson CM
(2009)
Bridging the gap: from protein misfolding to protein misfolding diseases.
FEBS Letters
583(16):
2581–2586.
Tyedmers J,
Mogk A and
Bukau B
(2010)
Cellular strategies for controlling protein aggregation.
Nature Reviews. Molecular Cell Biology
11(11):
777–788.
